Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02430428 · ClinicalTrials.gov registry record · NA
Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser
A NA study of Myopia and Astigmatism, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- NA
- Development phase
- 357
- Enrollment target
- 5
- Study locations
NCT02430428: Completed NA study of Myopia and Astigmatism, sponsored by Carl Zeiss Meditec.
NCT02430428 is a NA study of Myopia and Astigmatism that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 357 participants, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (35% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02430428, a NA study of Myopia and Astigmatism, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- NA
- Development phase
- 357 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -10.00 D with ≤ -3.00 D cylinder (myopia with or without astigmatism) and MRSE ≤ -11.50 D.
Primary Outcome
Predictability: Decrease in manifest refraction spherical equivalent (MRSE) to within ± 1.00 D and ± 0.50 D of the intended refractive outcome at the point at which stability is first reached
Conditions Studied
Interventions
- DEVICE Carl Zeiss Meditec VisuMax Femtosecond Laser
Study Locations (5)
Colorado
- Dishler Laser Institute - Greenwood Village
Kansas
- Discover Vision Centers - Leawood
South Dakota
- Vance Thompson Vision - Sioux Falls
Texas
- Slade and Baker Vision Center - Houston
Wisconsin
- Davis Duehr Dean - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT02430428 record still lists
NCT02430428 is an interventional study that assigns participants to a tested intervention. The registered 357 participants enrollment target is mid-sized for trials with a published cap, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (35% higher).
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Carl Zeiss Meditec VisuMax Femtosecond Laser is the first listed.
NCT02430428 lists 5 locations in 5 states (Colorado, Kansas, South Dakota).
Frequently Asked Questions
What is clinical trial NCT02430428 about?
NCT02430428 is a clinical study titled "Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser". The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -10.00 D with ≤ -3.00 D cylinder (myopia with or without astigmatism) and M...
What is the current status of trial NCT02430428?
This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2015-03. Estimated completion is 2017-10.
What conditions does trial NCT02430428 study?
This clinical trial studies the following conditions: Myopia, Astigmatism.
What interventions are being tested in trial NCT02430428?
The interventions under investigation include: Carl Zeiss Meditec VisuMax Femtosecond Laser (DEVICE).
Who is sponsoring clinical trial NCT02430428?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02430428 being conducted?
This trial has 5 study locations across Colorado, Kansas, South Dakota, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02430428's enrollment target sits among peer trials
357 13th of 90 higher than 78 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062888 · 357 participants · Phase 2
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
- NCT06109766 · 357 participants · NA
Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth
- NCT06231342 · 357 participants · NA
Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion
- NCT06533826 · 357 participants · Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia